Norbert Niederle

Learn More
BACKGROUND Rituximab plus chemotherapy, most often CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), is the first-line standard of care for patients with advanced indolent lymphoma,(More)
BACKGROUND Cetuximab and bevacizumab have both been shown to improve outcomes in patients with metastatic colorectal cancer when added to chemotherapy regimens; however, their comparative(More)
To assess the influence of pretransplant cytoreductive therapy with special reference to interferon-a (IFN-a) treatment on major endpoints of allogeneic bone marrow transplantation (BMT), we studied(More)